BACKGROUND AND OBJECTIVE
There are different techniques for reconstructing traumatic canalicular lacerations. The aim of this study is to report the surgical outcome with the Mini-Monoka monocanalicular stent (FCI Ophthalmics, Issy-Les Moulineaux, France).
PATIENTS AND METHODS
Patients with traumatic canalicular lacerations who underwent surgical reconstruction using the Mini-Monoka monocanalicular stent were included. The surgical outcome was based on subjective (epiphora) and objective (tear meniscus level, dye disappearance test, and lacrimal irrigation) findings after stent removal.
RESULTS
Nineteen patients (15 males, 4 females; mean age: 34 years) were included. The upper canaliculus was injured in 5 cases and the lower in 14 cases. Successful stenting was accomplished in all cases. Postoperative eyelid position was satisfactory in most patients. The mean period of stenting was 5 months and the mean postoperative follow-up period was 13 months. There were no cases of premature stent extrusion. Functional drainage after stent removal was normal in 94.7% of patients. Syringing showed full patency with no narrowing or reflux.
CONCLUSION
The Mini-Monoka monocanalicular stent is an effective tool in reconstructing traumatic canalicular lacerations. It is easy to use, carries a minimal risk of injury to the non-lacerated canaliculus, and results in high anatomical and functional success rates.
[Ophthalmic Surg Lasers Imaging 2010;41:472-477.]
AUTHORS
From the Oculoplastic and Lacrimal Division (IL), Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel; the Department of Ophthalmology (HK, VP), Aichi Medical University, Nagakute, Aichi, Japan; and the South Australian Institute of Ophthalmology and Department of Ophthalmology & Visual Sciences (HK, DS), University of Adelaide, South Australia, Australia.
Originally submitted June 6, 2009. Accepted for publication March 11, 2010. Posted online May 28, 2010.
The authors have no financial or proprietary interest in the materials presented herein.
Address correspondence to Igal Leibovitch, MD, Oculoplastic and Orbital Division, Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, 6 Weitzman Street, Tel-Aviv, 64239, Israel.
doi: 10.3928/15428877-20100525-05
